46brooklyn Research

“Drug prices are skyrocketing!” 🚀

“Drug prices are the lowest they’ve ever been!” 📉

Let’s cut through the noise by looking at the actual numbers.

Our latest at 46brooklyn.com

46brooklyn's Antonio Ciaccia joins The Patti Vasquez Show for a discussion on drug pricing and PBMs

Driving It Home with Patti Vasquez | January 29, 2026 Podcast Episode · Driving It Home with Patti Vasquez (Full Episodes) · 01/30/2026 · 1h 33m

“Independent analyses by 46brooklyn Research consistently show that multi-source generics have very low acquisition costs, while insured ‘negotiated prices’ are often an order of magnitude higher due to PBM pricing structures.”

When Insurance Stops Being Insurance: Medicare, UnitedHealth, and the Generic Drug Illusion My recent deep dive into Medicare drug pricing did not begin with pharmacy benefit managers or generic medications.

2025 year in review and an early look at 2026 list price hikes and cuts

Our latest:

2026 drug pricing reload: Out with the old, in with the new — 46brooklyn Research Drug prices at the end of 2025, and the start of 2026 As a non-profit, we at 46brooklyn have made it our goal to provide insights into U.S. drug pricing data available in the public domain. We do this by gathering data from often forgotten government websites or from tables of data that do not lend